Streetbeat News

Regulatory

BTCUSD

Robert F. Kennedy Jr., a pro-Bitcoin presidential hopeful for the 2024 election, is gaining support among Republican voters, according to a poll from Morning Consult. However, his favorability among Democratic voters has declined. Kennedy Jr. ranks second behind President Joe Biden in the hypothetical vote. His stance on Bitcoin could be winning over voters who see crypto regulations as an important issue.

Portfolio Pulse from Chris Katje

August 01, 2023 | 2:40 pm

AMZN

Amazon has announced the nationwide expansion of its virtual health clinic service, Amazon Clinic. The platform connects users with healthcare providers for common conditions. The service is available in all 50 states and Washington, D.C., for video visits, while message-based chat is available in 32 states due to regulatory issues. Amazon Clinic does not accept insurance, but insurance can be used for medications prescribed through the service. The company has partnered with Curai Health, Hello Alpha, SteadyMD, and Wheel for the provision of telemedicine services.

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 2:08 pm

DH

Definitive Healthcare has reported preliminary financial results for Q2 FY23, with expected revenue of $61.0 million and an adjusted net income of $12.3 million to $12.4 million. The company reaffirms its full year 2023 revenue and Adjusted EBITDA guidance. However, the company's previously issued financial statements should no longer be relied upon due to a restatement of historical financial results. This is due to a review of its sales tax positions, which revealed that sales in certain states were subject to sales tax that the company had not assessed. The company expects to record an aggregate increase to previously reported general and administrative expense of between $6.8 million to $10.2 million over the periods impacted.

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 1:55 pm

CVII

Trading of Churchill Capital Corp shares has been halted due to pending news. The nature of the news is not yet disclosed.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 1:53 pm

JAGX

Jaguar Health (NASDAQ:JAGX) announced the activation of a physician-requested Investigational New Drug (IND) application by the FDA to evaluate crofelemer for treatment of uncontrolled diarrhea in a patient with short bowel syndrome (SBS). The trial is supported by Napo Pharmaceuticals, a Jaguar company. Crofelemer has been granted Orphan Drug Designation (ODD) by the FDA and the European Medicines Agency (EMA) for SBS and microvillus inclusion disease (MVID).

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 1:51 pm

BLK

FXI

MSCI

SPY

The U.S. House of Representatives Select Committee on Chinese Communist Party has sent letters to Blackrock and MSCI. Blackrock has responded by stating that it complies with all applicable U.S. government laws and will continue to engage with the Select Committee directly on the issues raised.

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 1:49 pm

ATXI

Avenue Therapeutics, Inc. (NASDAQ:ATXI) announced that its drug BAER-101 significantly suppressed seizures in a preclinical animal model of absence epilepsy. The drug demonstrated full suppression of seizure activity with a minimal effective dose. BAER-101 has previously been shown to be safe with minimal side effects in clinical studies by AstraZeneca. The company plans to initiate a Phase 2a study in 2024.

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 1:48 pm

NRGV

Energy Vault Holdings, Inc. (NYSE:NRGV) has announced the commencement of commissioning of the world's first EVx Gravity Energy Storage System. The system, located in Rudong, Jiangsu Province, China, is expected to be fully interconnected to the local state utility grid in Q4 of this year. The 25 MW/100 MWh EVx GESS is built adjacent to a wind farm and a national grid interconnection site to augment and balance China's national energy grid through the storage and delivery of renewable energy. The company's gravity energy storage technology is also being used in other projects in China, including a 100 MWh gravity energy storage project in Huailai County, Hebei Province.

Portfolio Pulse from Happy Mohamed

August 01, 2023 | 1:29 pm

QLGN

Qualigen Therapeutics has received US FDA IND clearance to initiate Phase 1 clinical trial of QN-302 for the treatment of advanced or metastatic solid tumors. This clearance transitions Qualigen from a preclinical to a clinical-stage company and demonstrates its leadership in G4-targeting therapies for areas of high unmet need in oncology.

Portfolio Pulse from Benzinga Newsdesk

August 01, 2023 | 1:22 pm

CMND

SPRC

Clearmind Medicine Inc (NASDAQ:CMND) has filed a provisional patent application for the treatment of Dyskinesia with the US Patent and Trademark Office. The patent application refers to the psychedelic molecule 3-Methylmethcathinone (3-MMC) as a potential treatment for Dyskinesia. The patent application also includes protection for its unique combination of 3-MMC and SciSparc's Palmitoylethanolamide for Dyskinesia as part of its ongoing collaboration with SciSparc Ltd (NASDAQ:SPRC).

Portfolio Pulse from Vandana Singh

August 01, 2023 | 1:17 pm